The AGF US Market Neutral Anti-Beta Fund ETF is downgraded from 'Buy' to 'Hold' after significant underperformance and failure to hedge in 2026. BTAL's structure remains sector-neutral, shorting high-beta stocks and going long low-beta names, but poor individual stock selection led to negative -13.9% returns this year. Despite correct macro positioning, BTAL's active management failed to deliver intended negative beta exposure or effective downside protection in 2026.
For years, the standard 60/40 portfolio relied on a simple inverse relationship between equities and bonds. However, as volatility spikes, that safety net is fraying, and panelists at Exchange discussed responses to this challenge.
Commodity and defensive ETFs surged as Iran war tensions rattled markets, pushing several funds close to one-month highs.
AGF U.S. Market Neutral Anti-Beta Fund ETF (BTAL) excels as a tactical hedge, not a traditional buy-and-hold investment. BTAL monetizes the spread between low and high beta stocks, thriving in risk-off or overextended market environments. The ETF is delta-neutral by sector, reducing portfolio volatility and drawdowns, and improves Sharpe ratio when paired with equities.
BTAL offers a market-neutral strategy by going long low-beta and short high-beta U.S. stocks, providing S&P 500 hedging. The ETF plays the low vs. high beta spread, offering stronger short-term hedging and better long-term preservation than classic shorts. In my view, it must be included in a portfolio with a clear strategy; otherwise, it's dead weight, not added value.
AGF U.S. Market Neutral Anti-Beta Fund ETF is designed as a market-neutral equity hedge, long low-beta and short high-beta stocks, to benefit investors during market corrections. Despite its intent, the Fund has underperformed benchmarks and is best used only during significant market declines, not as a long-term core holding. Given current market conditions, I recommend a 'Sell' rating on BTAL. Despite my negative sentiment, BTAL could benefit from economic uncertainty and geopolitical risks.
BTAL is a market neutral ETF that profits from the spread between low and high beta stocks, ideal for hedging in volatile markets. The fund is long low beta stocks and short high beta stocks, thriving in down markets and reducing portfolio volatility. BTAL has shown strong performance in past bear markets and is expected to outperform in today's environment with stretched valuations.
The AGF U.S. Market Neutral Anti-Beta Fund ETF is a strong hedge against market downturns, outperforming the S&P 500 during recent volatility. BTAL's strategy involves going long on low-beta stocks and short on high-beta ones, providing a negative correlation to the S&P 500. A 33-67 allocation between UPRO and BTAL could offer superior risk-adjusted performance, with lower volatility and better Sharpe ratios than the S&P 500 alone.
BTAL is an ETF with a 1.72% total expense ratio, negative long-term returns, and is down most years. Its design is crazy, like a fox. BTAL is a market-neutral fund designed to perform well only in bear markets. When the market is down 10%, it averages 8.8% gains. In the 10% worst months for stocks, when the S&P is down 7%, BTAL averages 5% gains.
BTAL is an anti-beta market-neutral ETF, not beta-neutral, with imbalanced long and short positions. High-beta stocks fall further in market crashes, underperform in calm markets, and perform well after market bottoms. Tactical holding of BTAL based on VIX levels can provide a small performance boost and reduce drawdowns in market crashes.